Depression
Drug research and approvals for depression: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 1,458 studies of depression are recruiting on ClinicalTrials.gov, Health Canada has authorized 69 drug trials for it since 2013, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 1,458
- Trials authorized in Canada: 69
- FDA orphan approvals: 0
- EU medicines: 2
Recruiting now
Newest start dates first, of 1,458 recruiting on ClinicalTrials.gov ↗- Treatment of Depression Post-SCINCT04263285 · Not applicable · Medical University of South Carolina · starts May 1, 2027
- Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion DysregulationNCT07607730 · Not applicable · Children's Mercy Hospital Kansas City · starts Jan 1, 2027
- Mechanisms of Repeated Real-time Biofeedback With 7-Tesla MRI in DepressionNCT07694076 · Not applicable · University of Oxford · starts Dec 1, 2026
- A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic…NCT07227103 · Phase 2 / Phase 3 · NeuroRx, Inc. · starts Dec 1, 2026
- VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body DementiaNCT07637097 · Not applicable · University of Washington · starts Dec 1, 2026
- AI-Empowered Dignity Therapy for the Elderly in Community Integrated Care Centers and Daycare CentersNCT07939308 · Not applicable · Kaohsiung Medical University Chung-Ho Memorial Hospital · starts Nov 30, 2026
- Lakota Family Acceptance Project Pilot RCTNCT07865858 · Not applicable · University of Michigan · starts Nov 20, 2026
- Empagliflozin Adjunctive Therapy in Bipolar DepressionNCT07472920 · Not applicable · University of Sao Paulo · starts Nov 12, 2026
- Helping Kentuckians Overcome Depression and Opioid Addiction With Brain StimulationNCT07842601 · Not applicable · University of Kentucky · starts Nov 11, 2026
- PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low MoodNCT07848477 · Not applicable · University of Oxford · starts Nov 10, 2026
Drug pipeline
Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indicationsApproved 9
- DesipramineNorepinephrine transporter inhibitor
- DoxepinNorepinephrine transporter inhibitor
- EscitalopramSerotonin transporter inhibitor
- NefazodoneSerotonin transporter inhibitor
- NortriptylineSerotonin transporter inhibitor
- TrazodoneSerotonin transporter inhibitor
- IsocarboxazidMonoamine oxidase inhibitor
- LorazepamGABA-A receptor; anion channel positive allosteric modulator
- NaloxoneOpioid receptors; mu/kappa/delta antagonist
Phase 1 or earlier 7
- VortioxetineSerotonin 1a (5-HT1a) receptor agonist
- NavacaprantKappa opioid receptor antagonist
- PsilocybinSerotonin 2a (5-HT2a) receptor agonist
- Toludesvenlafaxine
- Azetukalner
- Itruvone
- Onfasprodil
How its trials ended
7,138 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 1,586 whose ending is known, 52% met their primary endpoint, 11% missed it and 37% stopped early.
- Completed, result not reported3,19745%
- Ongoing1,52921%
- Status unknown82612%
- Met its primary endpoint82011%
- Stopped: other or unclear3495%
- Missed its primary endpoint1722%
- Stopped: enrollment or feasibility1272%
- Stopped: sponsor or business decision491%
- Stopped: funding350%
- Stopped: lack of efficacy290%
- Stopped: safety50%
Trials authorized in Canada
The 10 newest of 69; search them all in Canada trials| Jul 22, 2026 | Does impaired brain insulin action underlie the shared risk of depression and diabetes and how does metformin affect it? an investigational neuroimaging and…Humalog / Metformin | Centre for Addiction and Mental Health | Pending |
| Oct 2, 2025 | A pilot randomized placebo-controlled trial of at home transcranial direct current stimulation and d-cycloserine augmentation in major depressionCycloserine | Governors of The University of Calgary | Pending |
| Sep 19, 2025 | Combining ketamine with dialectical behavioural therapy (DBT) for suicidality in individuals with treatment resistant depression and borderline personality…Ketamine / Midazolam | University Health Network | Ongoing |
| May 20, 2025 | Intravenous ketamine (IVK) versus personalized accelerated intermittent theta-burst stimulation (PAITBS) for treatment-resistant depression (TRD): a pilot…Ketamine | St Michaels Hospital | Pending |
| Mar 4, 2025 | Psilocybin-assisted therapy for treatment-resistant depression in bipolar ii disorder: a randomized controlled trialPsilocybin (PEX010) | University of British Columbia | Ongoing |
| Feb 4, 2025 | Clinical trial protocol title: evaluating the role of psilocybin monitors in psilocybin therapy for treatment resistant depression: a pilot randomized clinical…Psilocybin (PEX010) | Centre for Addiction and Mental Health | Ongoing |
| Jan 24, 2025 | Intravenous ketamine and immersive virtual reality to treat depression (treasure trial): a pilot, randomized controlled trialKetamine | Sunnybrook Research Institute | Ongoing |
| Dec 19, 2024 | Methohexital for treatment-resistant depression: a randomized, active placebo controlled pilot trialMethohexital/ Diphenhydramine | St. Michael's Hospital Unity Health Toronto | Closed |
| Nov 7, 2024 | Phase 2, multicenter, double-blind, randomized, placebo controlled trial to assess the efficacy, safety, and tolerability of repeated doses of VLS-01 buccal…Dimethyltryptamine (VLS-01-BU) | Atai Therapeutics, Inc. | Ongoing |
| Oct 23, 2024 | A double-blind, randomized trial of quetiapine versus trazadone in women with postpartum depressionTrazodone / Quetiapine | Dr Verinder Sharma | Closed |
Medicines authorised in the EU
Newest first| Nov 9, 2017 | NyxoidNaloxone | Mundipharma Corporation (Ireland) Limited | EMA ↗ |
| not available | ZurzuvaeZuranolone | Biogen Netherlands B.V. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA